Cardiac rehabilitation using the vCare virtual assistant yielded similar results to ambulatory rehabilitation and better results than a control group in patients with heart failure and ischemic heart disease.
Case-Control (n=50)
Does a virtual rehabilitation assistant (vCare) improve outcomes in heart failure and ischemic heart disease patients compared to ambulatory or control groups?
A virtual rehabilitation assistant provides comparable benefits to ambulatory cardiac rehabilitation and superior benefits to standard care in patients with heart failure and ischemic heart disease.
Cardiovascular diseases (CVDs) are the leading cause of mortality in Europe, with potentially more than 60 million deaths per year, with an age-standardized rate of morbidity-mortality higher in men than women, exceeding deaths from cancer. Heart attacks and strokes account for more than four out of every five CVD fatalities globally. After a patient overcomes an acute cardiovascular event, they are referred for rehabilitation to help them to restore most of their normal cardiac functions. One effective way to provide this activity regimen is via virtual models or telerehabilitation, where the patient can avail themselves of the rehabilitation services from the comfort of their homes at designated timings. Under the funding of the European Union's Horizon 2020 Research and Innovation program, grant no 769807, a virtual rehabilitation assistant has been designed for elderly patients (vCare), with the overall objective of supporting recovery and an active life at home, enhancing patients' quality of life, lowering disease-specific risk factors, and ensuring better adherence to a home rehabilitation program. In the vCare project, the Carol Davila University of Bucharest (UMFCD) was in charge of the heart failure (HF) and ischemic heart disease (IHD) groups of patients. By creating a digital environment at patients' homes, the vCare system's effectiveness, use, and feasibility was evaluated. A total of 30 heart failure patients and 20 ischemic heart disease patients were included in the study. Despite the COVID-19 restrictions and a few technical difficulties, HF and IHD patients who performed cardiac rehabilitation using the vCare system had similar results compared to the ambulatory group, and better results compared to the control group.
Lacraru et al. (Wed,) conducted a case-control in Heart failure and ischemic heart disease (n=50). vCare virtual rehabilitation assistant vs. Ambulatory rehabilitation and control group was evaluated on Effectiveness, use, and feasibility. Cardiac rehabilitation using the vCare virtual assistant yielded similar results to ambulatory rehabilitation and better results than a control group in patients with heart failure and ischemic heart disease.